BLFSBioLife Solutions, Inc.
36.51USD+0.10%Mkt Cap: 1.78B $P/E: 36.47

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The…

Key Statistics

Company
Market Cap1.78B $
Enterprise Value1.74B $
Revenue (TTM)106.69M $
Gross Profit62.12M $
Net Income (TTM)-4.59M $
Revenue/Share2.207 USD
Last Price36.51 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees155
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)36.47
P/E (Forward)112.03
PEG15.09
EV/EBITDA252.38
EV/Revenue16.32
P/S16.95
P/B4.30
EPS (TTM)1.01
EPS (Forward)0.33
52W Range
17.8698% of range36.91
52W High36.91 USD
52W Low17.86 USD
Profitability
Gross Margin64.56%
Oper. Margin5.96%
EBITDA Margin6.47%
Profit Margin-4.78%
ROE-1.24%
ROA-1.13%
Growth
Revenue Growth21.50%
Earnings Growth
Cash Flow & Leverage
Operating CF20.11M $
CapEx (TTM)19.70M $
FCF Margin4.37%
FCF Yield0.26%
Net Debt-66.68M $
Net Debt/EBITDA-9.66
Balance Sheet
Debt/Equity0.05
Current Ratio9.69
Quick Ratio6.67
Book Value/Sh8.591 USD
Cash/Share1.685 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:14
Split DateJan 29, 2014
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)31.29 USD
Upside (mean)-14.3%
Target Range31.00 USD33.00 USD
$31.00-14.3% to mean$33.00
# Analysts7
Ownership
Shares Out.48.91M
Float42.83M
Insiders2.37%
Institutions105.50%
Short Interest
Short Ratio3.1d
Short % Float14.54%
Short % Out.9.29%
Shares Short4.54M
Short (prev mo.)3.01M
Technical
SMA 5030.10 (+21.3%)
SMA 20024.87 (+46.8%)
Beta1.90
S&P 52W Chg18.16%
Avg Vol (30d)1.21M
Avg Vol (10d)510.46K
Technical Indicators
RSI (14)79.6
MACD1.8495
MACD Signal1.7069
MACD Hist.+0.1426
BB Upper37.15 USD
BB Middle33.09 USD
BB Lower29.03 USD
BB Width24.52%
ATR (14)1.089 USD
Vol Ratio (20d)0.47x